Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of ALLN-177 in Adult and Pediatric Subjects Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

NCT03391804 is registered in ClinicalTrials.gov with Allena Pharmaceuticals as lead sponsor.

NCT NCT03391804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of ALLN-177 in Adult and Pediatric Subjects Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
Lead sponsor
Allena Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
July 17, 2018
Completion date
December 13, 2019
Enrollment
15 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

enteric hyperoxaluria, hyperoxalemia, primary hyperoxaluria